-
inflammation and how this increases the risk for cancer and autoimmunity. This successful applicant will also be responsible for generating new proposals for intramural and extramural research funding both as a
-
development of drug-related adverse events, drug resistance, and drug efficacy) in cancer therapy. Applicants should have a strong background in mammalian cell culture and basic molecular biology techniques
-
Chen, Ph.D., in the Department of Neuroscience and Pharmacology at the University of Iowa. The research project is centered on the molecular mechanisms of obesity and cancer. The candidate is expected
-
. The successful candidate will join our Thrombosis/Vascular Biology Research Group, which uses novel genetic models to study mechanisms of thrombosis related to risk factors such as aging, diabetes, cancer
-
and motivated research scholar to join a research program in the general area of Artificial Intelligence/Big Data and their application to cancer treatment or related areas. The initial appointment is a
-
have a background in free radical, radiation, and/or cancer biology to apply for our upcoming openings on our highly successful and long running NIH National Cancer Institute T32. As the only free